methamphetamine has been researched along with raclopride in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (18.75) | 18.2507 |
2000's | 15 (46.88) | 29.6817 |
2010's | 11 (34.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albergati, A; Bo, P; Dallocchio, C; Marchioni, E; Savoldi, F | 1 |
Carino, MA; Horita, A; Ukai, Y | 1 |
Bennett, BA; Harp, JJ; Hollingsworth, CK; Martin, RS | 1 |
Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K | 1 |
Tsuchiya, K | 1 |
Björklund, A; Brooks, DJ; Brundin, P; Grasby, PM; Gunn, RN; Hagell, P; Lindvall, O; Piccini, P; Rehncrona, S; Rimoldi, O; Widner, H | 1 |
Gatley, SJ; Gifford, AN; Herman, LM; Kash, TL; Park, EH; Park, MH; Volkow, ND | 1 |
Kawabe, K; Maeda, J; Obayashi, S; Okauchi, T; Suhara, T; Suzuki, K | 1 |
Domino, EF; Harada, N; Kakiuchi, T; Miyasato, K; Nishiyama, S; Tsukada, H | 1 |
Brooks, DJ; Pavese, N; Piccini, P | 1 |
Doudet, DJ; Holden, JE | 1 |
Doudet, DJ; Holden, JE; Ruth, TJ | 1 |
Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R; Yoshimoto, M | 1 |
Ishikawa, A; Kadota, K; Kadota, T; Matsumura, H; Nakamura, S | 1 |
Alexander, M; Brasic, J; Kumar, A; Kuwabara, H; McCaul, ME; Munro, CA; Oswald, LM; Wand, GS; Wong, DF; Ye, W; Zhou, Y | 1 |
Chiba, T; Fukuda, T; Hatano, T; Hattori, N; Kai, N; Kakiuchi, T; Kobayashi, K; Mizuno, Y; Nishiyama, S; Sato, S; Tanaka, K; Tsukada, H; Yasoshima, Y | 1 |
Cho, AK; Fairbanks, LA; Jorgensen, MJ; Laćan, G; Melega, WP; Morton, G; Pham, J; Way, BM | 1 |
Fukakusa, A; Hayase, M; Ito, M; Kim, HC; Kumagai, N; Mizoguchi, H; Nabeshima, T; Nagai, T; Otsuka, N; Sato, K; Takuma, K; Yamada, K | 1 |
Alexoff, DL; Dewey, SL; Lee, DE; Patel, VD; Schiffer, WK | 1 |
Han, SM; Kim, SE | 1 |
Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H | 1 |
Jang, CG; Kim, HC; Lee, HK; Lee, SY; Yoo, JH | 1 |
Angulo, JA; Ghazaryan, N; Mexhitaj, I; Ordonez, D; Tulloch, I | 1 |
Alia-Klein, N; Fowler, JS; Hoffman, W; Jayne, M; Logan, J; Smith, L; Telang, F; Thanos, P; Tomasi, D; Volkow, ND; Wang, GJ; Wong, CT | 1 |
Atwell, K; Beauvais, G; Cadet, JL; Jayanthi, S; Ladenheim, B | 1 |
Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
Mitchell, SL; Sabol, KE; Speaker, HA; Yancey, DM | 1 |
Goda, Y; Hall, FS; Ito, M; Kikura-Hanajiri, R; Lesch, KP; Moriya, Y; Murphy, DL; Ohara, A; Piao, YS; Sora, I; Uhl, GR | 1 |
Gonzalez, AE; McDougall, SA; Mohd-Yusof, A; Rudberg, KN; Stone, MJ; Veliz, A | 1 |
Hong, SI; Hwang, JY; Jang, CG; Kim, HC; Lee, SY; Ma, SX; Oh, JH; Seo, JY | 1 |
Cho, J; Delis, F; Kim, R; Rocco, MJ; Thanos, PK; Volkow, ND | 1 |
Bernardi, A; Bisagno, V; Cadet, JL; García-Rill, E; Gomez, N; González, B; Jayanthi, S; Sosa, MH; Torres, OV; Urbano, FJ | 1 |
1 trial(s) available for methamphetamine and raclopride
Article | Year |
---|---|
Sex differences in striatal dopamine release in healthy adults.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Basal Ganglia; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Dominance, Cerebral; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methamphetamine; Positron-Emission Tomography; Putamen; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Sex Characteristics | 2006 |
31 other study(ies) available for methamphetamine and raclopride
Article | Year |
---|---|
Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit.
Topics: Animals; Arousal; Behavior, Animal; Benzazepines; Cortical Synchronization; Dopamine Antagonists; Electroencephalography; Haloperidol; Methamphetamine; Motor Cortex; Rabbits; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1991 |
The analeptic effect of methamphetamine in pentobarbital-narcotized rats is mediated via a dopaminergic-cholinergic mechanism.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Choline; Dopamine D2 Receptor Antagonists; Frontal Lobe; Hippocampus; Male; Methamphetamine; Pentobarbital; Quinuclidinyl Benzilate; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Salicylamides; Synaptosomes | 1994 |
Methamphetamine-induced alterations in dopamine transporter function.
Topics: Animals; Carrier Proteins; Cells, Cultured; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Nerve Tissue Proteins; Neurons; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |
Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1998 |
[Effects of methamphetamine on responsiveness to conditioned fear stress].
Topics: Animals; Benzamides; Benzazepines; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fear; Fluoxetine; Homovanillic Acid; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Raclopride; Rats; Rats, Wistar; Salicylamides; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1999 |
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Topics: Aged; Binding Sites; Brain Tissue Transplantation; Caudate Nucleus; Dopamine; Fetal Tissue Transplantation; Graft Survival; Humans; Male; Methamphetamine; Middle Aged; Neurons; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Substantia Nigra; Synapses; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
Topics: Amphetamine; Animals; Benzazepines; Corpus Striatum; Dopamine; Male; Methamphetamine; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
Topics: Animals; Binding Sites; Brain; Brain Mapping; Carbon Radioisotopes; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Macaca mulatta; Male; Methamphetamine; Neostriatum; Neurons; Pyrrolidines; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Reproducibility of Results; Salicylamides; Tomography, Emission-Computed | 2001 |
Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys.
Topics: Anesthesia; Animals; Arousal; Binding, Competitive; Carbon Radioisotopes; Central Nervous System Stimulants; Corpus Striatum; Dopamine Antagonists; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Raclopride | 2002 |
Endogenous dopamine release after pharmacological challenges in Parkinson's disease.
Topics: Aged; Binding Sites; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Fluorodeoxyglucose F18; Humans; Male; Methamphetamine; Middle Aged; Parkinson Disease; Putamen; Raclopride; Radiopharmaceuticals; Severity of Illness Index; Synapses; Tomography, Emission-Computed | 2003 |
Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: effect of methamphetamine.
Topics: Animals; Brain; Carbon Radioisotopes; Dopamine Antagonists; Dopamine Uptake Inhibitors; Macaca mulatta; Male; Methamphetamine; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Synaptic Transmission | 2003 |
Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: 2: effects of DAT inhibitors.
Topics: Animals; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Female; Heterocyclic Compounds, 2-Ring; Ligands; Macaca mulatta; Male; Methamphetamine; Models, Neurological; Oximes; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Time Factors | 2006 |
Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Methamphetamine; Motor Activity; Oxidopamine; Prosencephalon; Raclopride; Radionuclide Imaging; Rats; Rotation; Tissue Distribution | 2005 |
Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Hippocampus; Long-Term Potentiation; Male; Methamphetamine; Neural Pathways; Prefrontal Cortex; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Time Factors | 2005 |
Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Blotting, Southern; Central Nervous System Stimulants; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Exons; Methamphetamine; Mice; Mice, Knockout; Neostriatum; Positron-Emission Tomography; Postural Balance; Raclopride; Radiopharmaceuticals; Receptors, Dopamine; Sensory Receptor Cells; Ubiquitin-Protein Ligases | 2006 |
Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
Topics: Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Brain Chemistry; Central Nervous System Stimulants; Chlorocebus aethiops; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methamphetamine; Neurotoxicity Syndromes; Protein Binding; Raclopride; Social Behavior; Tritium | 2008 |
Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Animals; Benzazepines; Brain Chemistry; Cyclic AMP-Dependent Protein Kinases; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred ICR; Morphine; Nucleus Accumbens; Oxidopamine; Protein Kinase Inhibitors; Raclopride; Receptors, Dopamine D1; Signal Transduction; Sympatholytics; Synapses; Tissue Plasminogen Activator; Tyrosine 3-Monooxygenase | 2007 |
Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.
Topics: Animals; Brain; Carbon Radioisotopes; Dopamine; Dopamine Agents; Dopamine Antagonists; GABA Agents; Image Processing, Computer-Assisted; Male; Methamphetamine; Movement; Positron-Emission Tomography; Raclopride; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution; Vigabatrin | 2008 |
Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data.
Topics: Analysis of Variance; Animals; Brain; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Male; Methamphetamine; Microdialysis; Nicotine; Nicotinic Agonists; Protein Binding; Raclopride; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tritium | 2009 |
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase | 2009 |
GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Apomorphine; Autoradiography; Behavior, Animal; Benzazepines; Brain Mapping; Dopamine Agonists; Drug Interactions; Flunitrazepam; GABA Modulators; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Protein Binding; Raclopride; Receptors, GABA-A; Serotonin Antagonists; Tritium; Tropanes | 2010 |
Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.
Topics: Analysis of Variance; Androstanes; Animals; Benzazepines; Benzimidazoles; Bromodeoxyuridine; Cell Proliferation; Central Nervous System Stimulants; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Drug Administration Routes; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurogenesis; Neurokinin-1 Receptor Antagonists; Raclopride; Receptors, Dopamine; Receptors, Neurokinin-1 | 2011 |
Decreased dopamine activity predicts relapse in methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; Dopamine; Female; Humans; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Recurrence; Time Factors | 2012 |
Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways.
Topics: Animals; Benzazepines; Biomarkers; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fever; Heat-Shock Proteins; HSP40 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Male; Methamphetamine; Mitochondria; Neostriatum; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Stress, Physiological; Time Factors; Up-Regulation | 2011 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
Methamphetamine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker.
Topics: Animals; Body Temperature; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fever; Hypothermia; Male; Methamphetamine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Temperature | 2013 |
Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Topics: Animals; Benzazepines; Body Temperature; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Female; Fever; Male; Methamphetamine; Mice, Knockout; Models, Animal; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin Plasma Membrane Transport Proteins | 2015 |
Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Topics: Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Female; Methamphetamine; Motor Activity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2016 |
The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
Topics: Animals; Benzazepines; Butyrophenones; Conditioning, Psychological; Corpus Striatum; Designer Drugs; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Hylobatidae; Locomotion; Methamphetamine; Methylamines; Mice; Nucleus Accumbens; Raclopride; Receptors, Dopamine D1; Reward; Self Administration | 2018 |
Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Topics: Animals; Anxiety; Benzazepines; Body Weight; Brain; Carbon Isotopes; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Male; Methamphetamine; Psychomotor Performance; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recognition, Psychology; Signal Transduction; Spiperone | 2017 |
The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Chromatin Immunoprecipitation; Dopamine Agents; Epigenesis, Genetic; Excitatory Postsynaptic Potentials; Histone Deacetylase 1; Histones; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Modafinil; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Raclopride; Receptors, Biogenic Amine; Receptors, Dopamine | 2019 |